RxDoctor Payments Data

Christian Bermudez, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Philadelphia, PANPI 1083783179

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Abbott at 57.9% of the total. Reporting peaked in 2021 at $12,420 and has fallen 84.7% since, to $1,896 in 2025.

$22,000in general payments, 2019–2025

Across 56 payments — averaging $392.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$13K
  • Abiomed$6K
  • Transmedics, Inc.$2K
  • Atricure, Inc.$541
  • Medtronic$373
  • Livanova USA, Inc.$250
  • plus $551 from 3 others
$173,159in research payments, 2019–2025

Across 17 payments — averaging $10,186 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Xvivo Perfusion Inc.$88K
  • Livanova USA, Inc.$64K
  • Abbott$21K

What the payments were for

  • Consulting fees$10,37547%
  • Speaking & faculty fees$6,50030%
  • Travel & lodging$2,66712%
  • Food & beverage$2,45811%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott25$12,732
Abiomed13$6,006
Transmedics, Inc.3$1,549
Atricure, Inc.4$541
Medtronic(3 entities)4$373
Livanova USA, Inc.1$250
Xvivo Perfusion Inc.4$234
Edwards Lifesciences1$175
Artivion, Inc.1$142

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,000 in reported general payments places this provider in the 80th percentile of 314 thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$128,891
Medicare patients
48
Services billed
138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →